Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-117185
Filing Date
2024-10-24
Accepted
2024-10-24 21:28:19
Documents
2
Period of Report
2024-10-24

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5465
2 EX-24 ck0001984086-ex24.htm EX-24 14898
  Complete submission text file 0000950170-24-117185.txt   21814
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42382 | Film No.: 241393884

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Issuer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)